Kewei Li

Kewei Li


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2022 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
YZYaqi Zhang
Yaqi Zhang
GZGancheng Zhu
Gancheng Zhu
KLKewei Li
Kewei Li
LFLi Fei
Li Fei
LHLan Huang
Lan Huang
FZFengfeng Zhou
Fengfeng Zhou
Human Leukocyte Antigen (HLA) is a type of molecule residing on the surfaces of most human cells and exerts an essential role in the immune system responding to the invasive items. The T cell antigen receptors may recognize the HLA-peptide complexes on the surfaces of cancer cells and destroy these cancer cells through toxic T lymphocytes. The computational determination of HLA-binding peptides will facilitate the rapid development of cancer immunotherapies. This study hypothesized that the natural language processing-encoded peptide features may be further enriched by another deep neural network. The hypothesis was tested with the Bi-directional Long Short-Term Memory-extracted features from the pretrained Protein Bidirectional Encoder Representations from Transformers-encoded features of the class I HLA (HLA-I)-binding peptides. The experimental data showed that our proposed HLAB feature engineering algorithm outperformed the existing ones in detecting the HLA-I-binding peptides. The extensive evaluation data show that the proposed HLAB algorithm outperforms all the seven existing studies on predicting the peptides binding to the HLA-A*01:01 allele in AUC and achieves the best average AUC values on the six out of the seven k-mers (k=8,9,...,14, respectively represent the prediction task of a polypeptide consisting of k amino acids) except for the 9-mer prediction tasks. The source code and the fine-tuned feature extraction models are available at http://www.healthinformaticslab.org/supp/resources.php.

29 February 2024 in Bioinformatics
Verified
Journal Article
Open access
PDF file
RZRuochi Zhang
Ruochi Zhang
CWChao Wu
Chao Wu
QYQian Yang
Qian Yang
CLChang Liu
Chang Liu
YWYan Wang
Yan Wang
FZFengfeng Zhou
Fengfeng Zhou
Motivation: Predicting molecular properties is a pivotal task in various scientific domains, including drug discovery, material science, and computational chemistry. This problem is often hindered by the lack of annotated data and imbalanced class distributions, which pose significant challenges in developing accurate and robust predictive models. Results: This study tackles these issues by employing pretrained molecular models within a few-shot learning framework. A novel dynamic contrastive loss function is utilized to further improve model performance in the situation of class imbalance. The proposed MolFeSCue framework not only facilitates rapid generalization from minimal samples, but also employs a contrastive loss function to extract meaningful molecular representations from imbalanced datasets. Extensive evaluations and comparisons of MolFeSCue and state-of-the-art algorithms have been conducted on multiple benchmark datasets, and the experimental data demonstrate our algorithm’s effectiveness in molecular representations and its broad applicability across various pretrained models. Our findings underscore MolFeSCues potential to accelerate advancements in drug discovery. Availability and implementation: We have made all the source code utilized in this study publicly accessible via GitHub at http://www.healthinformaticslab.org/supp/ or https://github.com/zhangruochi/MolFeSCue. The code (MolFeSCue-v1-00) is also available as the supplementary file of this paper.

27 June 2023 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
YWYan Wang
Yan Wang
RZRuochi Zhang
Ruochi Zhang
SZShengde Zhang
Shengde Zhang
LGLiming Guo
Liming Guo
QZQiong Zhou
Qiong Zhou
FZFengfeng Zhou
Fengfeng Zhou

29 February 2024 in Analytical Biochemistry
Verified
Journal Article
Closed access
FLFei Li
Fei Li
JZJiale Zhang
Jiale Zhang
KLKewei Li
Kewei Li
YPYu Peng
Yu Peng
HZHaotian Zhang
Haotian Zhang
FZFengfeng Zhou
Fengfeng Zhou

21 October 2022 in Genes
Verified
Journal Article
Open access
PDF file
SLShuai Liu
Shuai Liu
YFYusi Fan
Yusi Fan
KLKewei Li
Kewei Li
HZHaotian Zhang
Haotian Zhang
XWXi Wang
Xi Wang
FZFengfeng Zhou
Fengfeng Zhou
Melanoma is a lethal skin disease that develops from moles. This study aimed to integrate multimodal data to predict metastatic melanoma, which is highly aggressive and difficult to treat. The proposed EnsembleSKCM method evaluated the prediction performances of long noncoding RNAs (lncRNAs), protein-coding messenger genes (mRNAs) and pathology images (images) for metastatic melanoma. Feature selection was used to screen for metastatic biomarkers in the lncRNA and mRNA datasets. The integrated EnsembleSKCM model was built based on the weighted results of the lncRNA-, mRNA- and image-based models. EnsembleSKCM achieved 0.9444 in the prediction accuracy of metastatic melanoma and outperformed the single-modal prediction models based on the lncRNA, mRNA and image data. The experimental data suggest the importance of integrating the complementary information from the three data modalities. WGCNA was used to analyze the relationship of molecular-level features and image features, and the results show connections between them. Another cohort was used to validate our prediction.

24 May 2023 in Genes
Verified
Journal Article
Open access
PDF file
LYlv ying
lv ying
XLXue Li
Xue Li
SCShihong Chen
Shihong Chen
GZGongyou Zhang
Gongyou Zhang
KLKewei Li
Kewei Li
HLHongmei Liu
Hongmei Liu
Background: Colon cancer (CC) is common, and the mortality rate greatly increases as the disease progresses to the metastatic stage. Early detection of metastatic colon cancer (mCC) is crucial for reducing the mortality rate. Most previous studies have focused on the top-ranked differentially expressed transcriptomic biomarkers between mCC and primary CC while ignoring non-differentially expressed genes. Results: This study proposed that the complicated inter-feature correlations could be quantitatively formulated as a complementary transcriptomic view. We used a regression model to formulate the correlation between the expression levels of a messenger RNA (mRNA) and its regulatory transcription factors (TFs). The change between the predicted and real expression levels of a query mRNA was defined as the mqTrans value in the given sample, reflecting transcription regulatory changes compared with the model-training samples. A dark biomarker in mCC is defined as an mRNA gene that is non-differentially expressed in mCC but demonstrates mqTrans values significantly associated with mCC. This study detected seven dark biomarkers using 805 samples from three independent datasets. Evidence from the literature supports the role of some of these dark biomarkers. Conclusions: This study presented a complementary high-dimensional analysis procedure for transcriptome-based biomarker investigations with a case study on mCC.